Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department
McCullough P.A., Hollander J.E., Nowak R.M., Storrow A.B., Duc P., Omland T., et al. Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. Acad Emerg Med 10 3 (2003) 198-204
The risk of myocardial infarction associated with inhaled β-adrenoceptor agonists
Au D.H., Lemaitre J., Curtis J.R., Smith N.L., and Psaty B.M. The risk of myocardial infarction associated with inhaled β-adrenoceptor agonists. Am J Respir Crit Care Med 161 (2000) 827-830
Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction
Au D.H., Curtis J.R., Every N.R., McDonell M.B., and Fihn S. Association between inhaled β-agonists and the risk of unstable angina and myocardial infarction. Chest 121 (2002) 846-851
Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis
Salpeter S.R., Ormiston T.M., and Salpeter E.E. Cardiovascular effects of β-agonists in patients with asthma and COPD: a meta-analysis. Chest 125 (2004) 2309-2321